BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24664275)

  • 1. External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review.
    Thorsteinsson AL; Vestergaard P; Eiken P
    Osteoporos Int; 2014 Jul; 25(7):1937-44. PubMed ID: 24664275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-induced osteonecrosis of the ear canal: our experience and a review of the literature.
    McCadden L; Leonard CG; Primrose WJ
    J Laryngol Otol; 2018 Apr; 132(4):372-374. PubMed ID: 29486808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the external auditory canal associated with oral bisphosphonate therapy: case report and literature review.
    Salzman R; Hoza J; Perina V; Stárek I
    Otol Neurotol; 2013 Feb; 34(2):209-13. PubMed ID: 23444468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.
    Vestergaard P; Schwartz K; Rejnmark L; Mosekilde L; Pinholt EM
    J Oral Maxillofac Surg; 2012 Apr; 70(4):821-9. PubMed ID: 21764202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-induced osteonecrosis of the external ear canal: a retrospective study.
    Froelich K; Radeloff A; Köhler C; Mlynski R; Müller J; Hagen R; Kleinsasser NH
    Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1219-1225. PubMed ID: 21327733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
    Eiken PA; Prieto-Alhambra D; Eastell R; Abrahamsen B
    Osteoporos Int; 2017 Oct; 28(10):2921-2928. PubMed ID: 28664276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-associated osteonecrosis of the auditory canal.
    Kharazmi M; Hallberg P; Persson U; Warfvinge G
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):e285-7. PubMed ID: 23523149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.
    Baillargeon J; Kuo YF; Lin YL; Wilkinson GS; Goodwin JS
    Ann Pharmacother; 2011 Oct; 45(10):1199-206. PubMed ID: 21954448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer.
    Goodwin JS; Zhou J; Kuo YF; Baillargeon J
    Mayo Clin Proc; 2017 Jan; 92(1):106-113. PubMed ID: 27876314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis.
    Park JH; Kwoen MJ; Lee JR; Kim KS; Lee HJ; Kim JW; Lee H
    Front Endocrinol (Lausanne); 2021; 12():774820. PubMed ID: 34956086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab and bisphosphonate associated bilateral osteonecrosis of the external auditory canal.
    True HD; Ricks RG; Smith JA
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34130974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.
    Khan AA; Rios LP; Sándor GK; Khan N; Peters E; Rahman MO; Clokie CM; Dore E; Dubois S
    J Rheumatol; 2011 Jul; 38(7):1396-402. PubMed ID: 21498483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
    Pazianas M; Abrahamsen B; Eiken PA; Eastell R; Russell RG
    Osteoporos Int; 2012 Nov; 23(11):2693-701. PubMed ID: 22392160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.
    Lapi F; Cipriani F; Caputi AP; Corrao G; Vaccheri A; Sturkenboom MC; Di Bari M; Gregori D; Carle F; Staniscia T; Vestri A; Brandi M; Fusco V; Campisi G; Mazzaglia G;
    Osteoporos Int; 2013 Feb; 24(2):697-705. PubMed ID: 22618266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
    Fung P; Bedogni G; Bedogni A; Petrie A; Porter S; Campisi G; Bagan J; Fusco V; Saia G; Acham S; Musto P; Petrucci MT; Diz P; Colella G; Mignogna MD; Pentenero M; Arduino P; Lodi G; Maiorana C; Manfredi M; Hallberg P; Wadelius M; Takaoka K; Leung YY; Bonacina R; Schiødt M; Lakatos P; Taylor T; De Riu G; Favini G; Rogers SN; Pirmohamed M; Nicoletti P; ; Fedele S
    Oral Dis; 2017 May; 23(4):477-483. PubMed ID: 28039941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
    J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia.
    Hong JW; Nam W; Cha IH; Chung SW; Choi HS; Kim KM; Kim KJ; Rhee Y; Lim SK
    Osteoporos Int; 2010 May; 21(5):847-53. PubMed ID: 19633881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bilateral bisphosphonate-associated osteonecrosis of the external ear canal : a rare case].
    Bast F; Fuss H; Schrom T
    HNO; 2012 Dec; 60(12):1127-9. PubMed ID: 23202871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study.
    Kim SH; Lee YK; Kim TY; Ha YC; Jang S; Kim HY
    Bone; 2021 Feb; 143():115650. PubMed ID: 32956854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.